Innovative Non-Invasive Direct Nose-To-Brain Delivery. SipNose devices enable new treatments for a wide variety of neurological disorders. The flexible platform is suitable for clinical or home use; for daily or emergency administration; pediatric, adult and geriatric patients.

SipNose

Yokneam

SipNose startup from Yokneam, Israel is ranked 49998 out of 97194 worldwide and 911 from the 1746 startups in Israel. See more information and additional rankings on the StartupBlink Global Ecosystem Map